Exenatide once weekly for alcohol use disorder investigated in a ...
BackgroundAlcohol use disorder (AUD) is a chronic, relapsing brain disorder that accounts for 5% of deaths annually, and there is an urgent need to develop new targets for therapeutic intervention. The glucagonlike peptide1 (GLP1) receptor agonist exenatide reduces alcohol consumption in rodents .